Key Takeaways
- Confirm that the specific hospital campus is currently approved for the exact service proposed—conventional IVF-ET, ICSI or PGT—not simply that it offers “fertility treatment.” China regulates each assisted-reproduction technology through provincial approval and publishes institutional lists.[1][2]
- Ask the clinic to pre-check eligibility and documents before flights are booked. Published national technical and ethical principles require identity documents and proof of marriage, including passports and marriage documentation for foreign or mixed-nationality couples; the receiving centre should confirm its current originals, translation and authentication requirements.[3]
- One IVF cycle is a sequence, not one guaranteed transfer: ovarian stimulation and monitoring may be followed by cancellation, egg retrieval, fertilisation, embryo culture, fresh transfer, freezing or a later frozen transfer.
- Age at egg retrieval, diagnosis, ovarian response, sperm factors and treatment history affect prognosis. Ovarian-reserve tests help plan stimulation but do not independently predict natural fertility or guarantee the number of usable embryos.[4]
- Compare live birth and cumulative outcomes using a stated denominator. A rate “per transfer” excludes cycles that never reached transfer and can look more favourable than a rate per intended or actual retrieval.[5]
- More embryos are not a shortcut to a healthy baby. The number transferred should be a documented clinical decision that considers multiple-pregnancy risk; ESHRE guidance is designed around the goal of a healthy pregnancy and birth.[6]
Content
IVF abroad asks two questions at once: Is this treatment medically appropriate? and Can this particular institution lawfully and safely deliver it to this patient? A polished quotation or a famous city answers neither. The useful starting point is a written eligibility review, a diagnosis-led treatment proposal and confirmation of the centre's current authorization.
WHO describes infertility as a disease of the male or female reproductive system and notes that male, female and unexplained factors can contribute.[7] That matters because “IVF package” is not a diagnosis. Some people need treatment before IVF, some need a different fertility pathway, and some should not lose time on tests that will not change management.
First confirm whether China is a workable destination for this case
China's administrative measures state that assisted reproductive technology must be performed in approved medical institutions for medical purposes, with appropriate personnel, facilities and ethics oversight.[2] Commercial trade in gametes, zygotes or embryos and surrogacy are prohibited under those measures. Published national ethical principles also prohibit non-medical sex selection and set document and consent requirements.[3]
Before paying a deposit, send the receiving centre a short factual profile and ask for a written response:
- nationalities, ages and marital status of both intended patients;
- passport names exactly as printed and the country that issued the marriage record;
- fertility diagnosis, pregnancy history and previous treatment;
- whether own eggs and sperm are planned or any third-party material is being considered;
- whether conventional IVF, ICSI, PGT, surgical sperm retrieval or fertility preservation is being requested; and
- whether either person can attend every consent, collection and transfer step that requires them.
The published national principles say foreign and mixed-nationality couples should provide passports and proof of marriage.[3] They do not settle every practical question about translations, notarisation, visa status, document validity, treatment of particular family structures or local implementation. Ask the named hospital—not an unaffiliated broker—to list the documents it will accept and to confirm eligibility before travel. Rules and institutional interpretation can change.
Verify the exact technology, campus and approval status
The National Health Commission's planning principles distinguish husband-sperm insemination, donor-sperm insemination, conventional IVF-ET, ICSI, PGT and sperm-bank services.[1] Approval for one category should not be treated as approval for all of them. Provincial health authorities are responsible for planning, approval and oversight, and the national commission maintains an information page for approved institutions.[8]
Ask the hospital to provide:
- its current legal name and exact treatment campus;
- the approving health authority and current approved technology categories;
- the legal entity that will issue invoices, consent forms and medical records;
- the named reproductive endocrinologist and laboratory director responsible for the cycle; and
- whether any monitoring, retrieval, testing or storage is outsourced and, if so, to whom.
A business licence, hospital website or general obstetrics department is not evidence that an embryology laboratory is approved for PGT or another advanced technique. Verify the institution through the relevant official list and obtain written confirmation when the proposed service is not clearly shown.
Build the plan around the infertility diagnosis
An initial evaluation should be systematic and should assess both partners when applicable. ASRM advises obtaining a male partner's reproductive and medical history and at least one semen analysis at the outset because male factors are common.[4] For the person providing eggs or carrying the pregnancy, the work-up is tailored to age, menstrual and ovulation history, pregnancy history, pelvic disease, treatment history and the planned procedure.
The case packet commonly includes:
- menstrual pattern, prior pregnancies, miscarriages and ectopic pregnancy;
- infertility duration and previous stimulation, retrieval, fertilisation and embryo outcomes;
- pelvic ultrasound with antral follicle count when clinically relevant;
- AMH, FSH and estradiol interpreted in clinical context rather than as a stand-alone “fertility score”;
- assessment of the uterine cavity and fallopian tubes when it could alter treatment;
- semen analysis and additional male evaluation when indicated;
- infection screening required by the centre and destination rules;
- genetic history, carrier results and counselling when PGT or inherited disease is relevant; and
- medical conditions and medicines that affect anaesthesia, stimulation or pregnancy.
Evaluation should be expedited for older patients or known fertility-threatening conditions rather than automatically waiting 12 months. ASRM says evaluation may start at six months for women aged 35 or older, more immediately over 40, and without delay when a condition known to impair fertility is present.[4]
Make the treatment choice explicit
The written plan should state why IVF is being recommended and what alternatives remain reasonable. It should also separate conventional IVF from ICSI. In ICSI, a single sperm is injected into an egg; it may be appropriate for defined sperm-related or laboratory indications, but it is not an automatic upgrade for every cycle. ASRM's 2026 opinion reports no improvement in live birth, euploidy or embryo numbers from using ICSI for PGT-A in the absence of male-factor infertility.[9]
If PGT is proposed, ask which test—PGT-M, PGT-SR or PGT-A—answers which question. Clarify the condition or chromosome finding being investigated, test limitations, mosaic or inconclusive-result policy, need for parental samples, embryo-biopsy and freezing plan, and whether prenatal diagnostic testing may still be advised. “Genetically tested” does not mean screened for every disease, and PGT does not guarantee implantation or a healthy child.
Understand what can change during stimulation
Stimulation usually involves injectable medicines followed by ultrasound and hormone monitoring. The dose and visit schedule may change as follicles respond. The clinic should explain:
- the medication names, storage conditions and exact local dosing time;
- who reviews each scan and laboratory result;
- the criteria for changing dose, triggering final maturation, cancelling or converting the cycle;
- the plan for unexpectedly low or high response; and
- how to contact a clinician after hours.
Ovarian hyperstimulation syndrome (OHSS) can range from mild symptoms to serious fluid shifts, breathing difficulty and thrombosis risk. Ask how the centre estimates risk, adjusts the trigger, decides on a “freeze-all” cycle and follows the patient after retrieval. Rapidly increasing abdominal swelling, severe or worsening pain, persistent vomiting, reduced urination, shortness of breath, chest pain, faintness or a swollen painful leg warrants urgent assessment. An international itinerary must leave room for unexpected monitoring or delayed travel.
Treat retrieval and the laboratory as safety-critical steps
Egg retrieval is an invasive procedure, often performed with sedation or anaesthesia. The patient should know the fasting instructions, anaesthesia assessment, pain plan, discharge criteria and whom to contact for fever, heavy bleeding, increasing pain or faintness. “Ten follicles,” “ten eggs retrieved” and “ten mature eggs” are different numbers; the record should distinguish them.
The embryology laboratory should describe its identity and witnessing system from collection through storage. Ask how it documents:
- oocytes retrieved and mature;
- fertilisation method and results;
- day-by-day embryo development;
- biopsy, freezing and warming events;
- embryo identifiers and chain of custody;
- equipment alarms, backup power and disaster response; and
- consent for storage, disposition and contact loss.
Attrition between retrieved eggs, mature eggs, normally fertilised eggs, developing embryos and transferable embryos is expected biology. A responsible team explains each denominator instead of presenting only the most flattering stage.
Decide on transfer with the goal of a healthy singleton birth
Fresh transfer is not automatically better than frozen transfer, and “freeze-all” is not automatically better for everyone. The decision depends on response, uterine factors, hormone environment, PGT, OHSS risk and clinical circumstances.
The transfer discussion should record embryo stage and source, number proposed, embryo-selection method, endometrial preparation, luteal support and what will happen to remaining embryos. ESHRE's embryo-transfer guideline provides recommendations for deciding between one and two embryos and cautions against using the guidance to justify double transfer when multiple pregnancy must be avoided.[6]
Ask for the risk in terms of singleton live birth, twins or higher-order multiples—not simply a positive pregnancy test. Multiple pregnancy increases obstetric and neonatal risk. Transferring more embryos may also reduce future options by using embryos that could have been transferred separately.
Read success rates without being sold a denominator
CDC explains that ART outcomes may be reported per intended retrieval, actual retrieval, transfer or cumulatively across transfers following a retrieval.[5] These are not interchangeable. A clinic can appear stronger if it quotes pregnancy per transfer and leaves out cancelled cycles, failed fertilisation, cycles with no transferable embryo, miscarriages or patients it declined to treat.
Request a table that matches the patient's situation and states:
- age at egg retrieval and whether own or donor eggs were used;
- fresh versus frozen and tested versus untested embryos;
- number of started cycles, retrievals and transfers;
- cancellation and no-transfer rates;
- clinical pregnancy, miscarriage and live-birth rates;
- cumulative live birth after all transfers from one retrieval, with a defined follow-up period; and
- singleton live birth and multiple-birth rates.
Small groups produce unstable percentages; one birth from one transfer is 100% but tells little about future patients.[5] No credible centre can guarantee pregnancy, a euploid embryo or a live birth.
Plan cryostorage and cross-border movement before creating embryos
The consent should identify what may be stored, storage location, annual fees, payment failures, contact-update duties, maximum storage rules, disposition choices and what happens after death, separation or disagreement. Obtain an inventory after every freezing, warming, biopsy or transfer event.
Do not assume frozen sperm, eggs or embryos can be couriered internationally later. Before treatment, get written confirmation from the Chinese centre, the receiving clinic, a specialist cryogenic courier and relevant authorities covering release, export, import, infectious-disease documents, tank validation, customs handling, identity matching and legal acceptance. If any link cannot confirm the transfer, plan on material remaining where it was created. A broker's verbal assurance is not enough.
Design the trip around clinical uncertainty
Ask which monitoring can be completed at home, which results the Chinese physician will accept and how time zones affect same-day dose changes. Carry medicines in original packaging with a prescription and check airline, transit-country and Chinese entry requirements. Do not alter a trigger time because of a flight without the clinic's instruction.
The quotation should separate consultation, tests, medicines, monitoring, anaesthesia, retrieval, IVF or ICSI, culture, biopsy, genetics laboratory, freezing, first-year storage, transfer, pregnancy medicines and complication care. Ask what happens financially if the cycle is cancelled, no egg is retrieved, fertilisation fails or no embryo is suitable for transfer.
Before leaving China, collect an English or professionally translated record containing the stimulation sheet, ultrasound and hormone results, trigger and retrieval details, anaesthesia record, egg maturity, fertilisation method, embryology development, biopsy results, transfer note, embryo inventory, medicines and emergency plan. If pregnant, arrange quantitative testing and ultrasound to confirm location and viability; IVF does not remove the possibility of ectopic pregnancy or miscarriage.
Medical disclaimer: This article provides general education and cannot determine eligibility, choose an IVF protocol or predict an individual outcome. Assisted-reproduction law, institutional authorization and document requirements can change; confirm them directly with the licensed centre and relevant authorities. Urgent symptoms require local medical assessment.
FAQ
Can an unmarried international patient receive IVF in China?
Published national technical and ethical principles require identity and marriage documentation and state that assisted reproduction should not be performed for single women.[3] Eligibility and implementation can change, so obtain a written pre-assessment from the licensed hospital before paying or travelling; do not rely on a facilitator's promise.
Does approval to offer IVF mean a clinic can also perform ICSI or PGT?
No. China's planning framework treats conventional IVF-ET, ICSI and PGT as distinct technology categories.[1] Check the exact campus and current approved scope through official information and ask the hospital to confirm it in writing.
Is ICSI better than conventional IVF for every patient?
No. ICSI can be appropriate for particular male-factor, fertilisation or genetic-testing circumstances, but it is not a universal quality upgrade. The laboratory and doctor should document the indication and discuss conventional IVF, ICSI or a split approach when appropriate.[9]
Which IVF success-rate number should I compare?
Start with live birth per intended or actual retrieval and cumulative live birth after all transfers from that retrieval, matched by age and egg source. Also ask for cancellation, no-transfer, miscarriage and singleton outcomes. Pregnancy per transfer alone omits important earlier steps.[5]
Can frozen embryos be shipped from China to another country later?
Do not assume so. Release, export, import, infectious-disease testing, cryogenic transport, receiving-laboratory compatibility and legal eligibility all need written confirmation before the cycle. If any party cannot approve the route, the embryos may need to remain at the original storage site.
Sources
- National Health Commission of China — Guiding Principles for Planning the Application of Human Assisted Reproductive Technology (2021)
- National Health Commission of China — Administrative Measures for Human Assisted Reproductive Technology
- National Health Commission of China — Technical Specifications, Ethical Principles and Basic Standards for Human Assisted Reproductive Technology
- American Society for Reproductive Medicine — Fertility Evaluation of Infertile Women: A Committee Opinion (2021)
- US Centers for Disease Control and Prevention — How to Interpret ART Success Rates
- European Society of Human Reproduction and Embryology — Guideline on the Number of Embryos to Transfer During IVF/ICSI
- World Health Organization — Infertility Fact Sheet
- National Health Commission of China — Approved Human Assisted Reproductive Technology Institutions
- American Society for Reproductive Medicine — ICSI for Non-Male-Factor Indications: Committee Opinion (2026)
Image Review
- Decision: Approved and retained as hero-reviewed.png.
- Editorial note: The image shows a doctor, an international couple, embryo-development imagery and a Chinese city setting. It is directly relevant to IVF care in China and does not depict a named institution, a specific embryo result or a guaranteed pregnancy.